Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]

View source ↗

Summary

Phase 3 trial update for brepocitinib in adults with dermatomyositis indicates ongoing investigation of efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• Brepocitinib (brepocitinib)

Snippet

Sponsor: Priovant Therapeutics, Inc. | Conditions: Dermatomyositis | Phase 3 | Status: ACTIVE_NOT_RECRUITING